Tudor Investment Corp
TXG icon

Tudor Investment Corp’s 10x Genomics TXG Stock Holding History

Tudor Investment Corp’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-76,909
Closed -$899K – 4069
2025
Q3 		$899K Buy
76,909
+44,206
+135% +$576K ﹤0.01% 2348
2025
Q2 		$379K Buy
32,703
+17,310
+112% +$158K ﹤0.01% 2754
2025
Q1 		$134K Sell
15,393
-184,618
-92% -$2.33M ﹤0.01% 2916
2024
Q4 		$2.87M Sell
200,011
-109,061
-35% -$1.72M 0.01% 1011
2024
Q3 		$6.98M Buy
309,072
+72,942
+31% +$1.51M 0.03% 560
2024
Q2 		$4.59M Buy
236,130
+154,518
+189% +$4.05M 0.02% 690
2024
Q1 		$3.06M Buy
81,612
+17,720
+28% +$779K 0.02% 818
2023
Q4 		$3.58M Buy
63,892
+49,609
+347% +$2.16M 0.03% 805
2023
Q3 		$589K Sell
14,283
-156,789
-92% -$8.16M 0.01% 1598
2023
Q2 		$9.55M Buy
171,072
+129,417
+311% +$7M 0.11% 182
2023
Q1 		$2.32M Buy
41,655
+6,008
+17% +$281K 0.04% 711
2022
Q4 		$1.3M Buy
+35,647
New +$1.17M 0.03% 914
2022
Q3 		– Sell
-82,997
Closed -$3.76M – 2725
2022
Q2 		$3.76M Buy
82,997
+43,165
+108% +$2.24M 0.1% 257
2022
Q1 		$3.03M Buy
+39,832
New +$3.48M 0.07% 361
2021
Q1 		– Sell
-5,122
Closed -$725K – 1864
2020
Q4 		$725K Sell
5,122
-46,174
-90% -$6.7M 0.02% 808
2020
Q3 		$6.4M Buy
+51,296
New +$5.38M 0.28% 57
2019
Q4 		– Sell
-11,368
Closed -$573K – 1386
2019
Q3 		$573K Buy
+11,368
New +$629K 0.02% 676

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tudor Investment Corp's TXG Position: Q4 2025 in Review

Tudor Investment Corp sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 76,909 shares — an estimated $899K sold.

Tudor Investment Corp first reported a position in TXG in Q3 2019 and held it in 17 quarters. The position peaked at $9.55M in Q2 2023. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Tudor Investment Corp reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 76,909 10x Genomics shares in Q4 2025, an estimated $899K.
  • Tudor Investment Corp first reported a position in 10x Genomics in Q3 2019 and held it in 17 quarters.
  • Tudor Investment Corp's 10x Genomics position peaked at $9.55M in Q2 2023.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.